Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis.
Expert Rev Anti Infect Ther
January 2017
a WHO Collaborating Centre for the Prevention and Treatment of Human Echinococcosis; Centre National de Référence pour l'Echinococcose alvéolaire; & Department of Gastroenterology, Digestive Endoscopy and Nutrition , University of Franche-Comté and University Hospital, Besançon , France.
Background: Biliary complications represent a turning point in the course of Alveolar Echinococcosis (AE). We conducted a European survey to collect data on the current usage and results of perendoscopic interventions (PEIs) for their treatment.
Methods: Patient's characteristics and follow-up until January 31st, 2015 were recorded using an online questionnaire.
Current interventional strategy for the treatment of hepatic alveolar echinococcosis.
Expert Rev Anti Infect Ther
December 2016
a WHO-Collaborating Centre for Prevention and Treatment of Human Echinococcosis & French National Centre for Alveolar Echinococcosis (Director: Laurence Millon) , University of Franche-Comté and University Hospital, Besançon , France.
The use of various types of invasive interventions combined with anti-infective drugs in the therapeutic strategy of alveolar echinococcosis (AE) has changed during the last 30 years. Areas covered: This article reviews the current respective indications of surgical, percutaneous and perendoscopic interventions in AE and proposes an integrative therapeutic strategy. Expert commentary: Hepatic resection is indicated whenever it is feasible and curative; palliative surgery should be avoided; percutaneous procedures are best adapted to the drainage of the necrotic cavity present in advanced cases; perendoscopic procedures with stenting are best adapted to alleviating the biliary complications that are common and life-threatening in AE patients.
View Article and Find Full Text PDF[Percutaneous transhepatic biliary manometry].
Korean J Gastroenterol
March 2007
Department of Gastroenterology, Ajou University School of Medicine, Woncheon-dong, Yeongtong-gu, Suwon, Korea.
Perendoscopic biliary manometry may not represent the overall sphincter of Oddi (SO) motility, as the recording time is relatively short and it is possibly influenced by the presence of an endoscope in duodenum and air inflation. Percutaneous transhepatic biliary manometry of SO permits long-term recordings without patient discomfort and risk of complications. We investigated the change of human SO motility and the correlation between SO motility and migrating motor complex (MMC) of the small bowel in a fasting state by long-term simultaneous manometric examination of SO and small bowel.
View Article and Find Full Text PDFEffect of native somatostatin on Sphincter of Oddi motility in patients with acute recurrent pancreatitis. A pilot study with Ultrasound-Secretin test.
Dig Liver Dis
April 2006
Department of Biomedical and Surgical Sciences, University of Verona, Verona, Italy.
Background: The effect of native somatostatin on Sphincter of Oddi motility still remains controversial. Sphincter of Oddi inhibition was demonstrated at manometry in patients in the acute phase of alcoholic pancreatitis. Other investigators showed marked somatostatin-induced impairment of bile flow by hepato-biliary scintigraphy.
View Article and Find Full Text PDFBackground: Sphincter of Oddi dysfunction is diagnosed at manometry and, after cholecystectomy, non-invasively at quantitative choledochoscintigraphy. Patients may benefit from endoscopic sphincterotomy.
Aims: The aim of this study was to assess the usefulness of choledochoscintigraphy compared with manometry in predicting outcome of sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!